These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17674193)

  • 1. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
    Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
    Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
    Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
    Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
    Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
    Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.
    Loaiza-Pérez AI; Trapani V; Hose C; Singh SS; Trepel JB; Stevens MF; Bradshaw TD; Sausville EA
    Mol Pharmacol; 2002 Jan; 61(1):13-9. PubMed ID: 11752201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
    Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
    Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445).
    Bradshaw TD; Chua MS; Orr S; Matthews CS; Stevens MF
    Br J Cancer; 2000 Jul; 83(2):270-7. PubMed ID: 10901382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.
    Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF
    Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling.
    Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD
    J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.
    Brantley E; Antony S; Kohlhagen G; Meng L; Agama K; Stinson SF; Sausville EA; Pommier Y
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):62-72. PubMed ID: 16331501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
    Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
    Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
    Stone EL; Citossi F; Singh R; Kaur B; Gaskell M; Farmer PB; Monks A; Hose C; Stevens MF; Leong CO; Stocks M; Kellam B; Marlow M; Bradshaw TD
    Bioorg Med Chem; 2015 Nov; 23(21):6891-9. PubMed ID: 26474663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.
    Bradshaw TD; Westwell AD
    Curr Med Chem; 2004 Apr; 11(8):1009-21. PubMed ID: 15078163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
    Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
    Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.
    Bradshaw TD; Stevens MF; Westwell AD
    Curr Med Chem; 2001 Feb; 8(2):203-10. PubMed ID: 11172675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.
    Wang K; Guengerich FP
    Chem Res Toxicol; 2012 Aug; 25(8):1740-51. PubMed ID: 22734839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
    McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
    Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
    de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
    Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
    Spink BC; Fasco MJ; Gierthy JF; Spink DC
    J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of MCF-7 cells to dimethylbenz(a)anthracene-induced apoptosis is due to reduced CYP1A1 expression.
    Ciolino HP; Dankwah M; Yeh GC
    Int J Oncol; 2002 Aug; 21(2):385-91. PubMed ID: 12118336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.
    Kashiyama E; Hutchinson I; Chua MS; Stinson SF; Phillips LR; Kaur G; Sausville EA; Bradshaw TD; Westwell AD; Stevens MF
    J Med Chem; 1999 Oct; 42(20):4172-84. PubMed ID: 10514287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.